ALEMBIC PHARMACEUTICALS
Back to Income Statement
|
ALEMBIC PHARMACEUTICALS Last 5 Year Revenue History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Sales | ₹7,345 Cr | ₹6,672 Cr | ₹6,229 Cr | ₹5,653 Cr | ₹5,306 Cr |
What is the latest Revenue of ALEMBIC PHARMACEUTICALS ?
| Year | Revenue |
|---|---|
| Mar2026 | ₹7,345 Cr |
| Mar2025 | ₹6,672 Cr |
| Mar2024 | ₹6,229 Cr |
| Mar2023 | ₹5,653 Cr |
| Mar2022 | ₹5,306 Cr |
How is Revenue of ALEMBIC PHARMACEUTICALS Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2026 | ₹7,345 Cr | 10.08 | |
| Mar2025 | ₹6,672 Cr | 7.12 | |
| Mar2024 | ₹6,229 Cr | 10.19 | |
| Mar2023 | ₹5,653 Cr | 6.54 | |
| Mar2022 | ₹5,306 Cr | - | |
Compare Revenue of peers of ALEMBIC PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ALEMBIC PHARMACEUTICALS | ₹16,384.6 Cr | 2.5% | 12.3% | -15.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹470,786.0 Cr | 0.8% | 7.3% | 15.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹194,590.0 Cr | 1.9% | 8.2% | 6.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹191,658.0 Cr | 0.6% | 12.6% | 43.9% | Stock Analytics | |
| CIPLA | ₹115,728.0 Cr | 0.2% | 6.3% | -4.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,708.0 Cr | -1.8% | -3.5% | -3.4% | Stock Analytics | |
ALEMBIC PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ALEMBIC PHARMACEUTICALS | 2.5% |
12.3% |
-15.5% |
| SENSEX | 0.5% |
0.1% |
-6.1% |
You may also like the below Video Courses